Medibank (MPL.AX)

Overall impact
B (61)

Commentary

Medibank is a strong overall performer. With a 'B' rating of 60.5 for overall impact (64th percentile compared to all companies), Medibank ranks 25th out of 47 industry peers, behind Allianz, Zurich Insurance, AXA and 21 others, and ahead of Goosehead Insurance, Swiss Life, Gjensidige Forsikring and 19 others. On top material causes for Medibank's industry (Insurance), Medibank performs well in Disaster Readiness and Effective Aid (95.8 score) and Equal Pay and Opportunity (95.7) and performs poorly in Access to Affordable Healthcare (39.1 score) and Free, Secure Flow of Information (0.3).
Impact
Cause MPL.AX
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
3,220
Sector
Financials
Industry
Insurance
Sub-industry
Multi-line Insurance
SASB industry
Insurance
Headquarters
Vic, Australia
Share classes
MPL.AX
Description
Medibank Private Limited provides private health insurance and health services in Australia. The company operates in two segments, Health Insurance and Medibank Health. The Health Insurance segment provides private health insurance products, including hospital cover that offers members with health cover for hospital treatments; and ancillary cover, which provides members with health cover for healthcare services, such as dental, optical, and physiotherapy. This segment also offers health insurance products to overseas visitors and overseas students. The Medibank Health segment provides health management and in-home care services, as well as a range of telehealth services to government and corporate customers; and distributes travel, life, and pet insurance products. It underwrites its health insurance products under the Medibank and ahm brands. The company was founded in 1976 and is based in Docklands, Australia.
Material causes
Ethos considers the following causes material for Medibank, based on its industry sub-industry Multi-line Insurance. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.